Mode
Text Size
Log in / Sign up
Neurology 2026-W26 · Published Jul 22, 2026

This Week in Neurology: Parkinson Disease Management and Stroke Intervention Strategies

Research this week highlighted various pharmacological and therapeutic approaches for managing motor symptoms in Parkinson disease. In the Journal of Neurology, a network meta-analysis of randomized controlled trials evaluated adjunct therapies for Asian patients experiencing motor fluctuations [3].

The analysis suggested that safinamide 100 mg outperformed both rasagiline 1 mg and zonisamide 25 mg in reducing OFF-time and improving motor scores [3].

Additionally, research published in Neurology reported on the use of fecal microbiota transplantation (FMT) for patients with mild to moderate Parkinson disease [5].

A meta-analysis of 220 adults found that FMT significantly improved constipation symptoms and motor function as measured by UPDRS part III, though the authors noted these effects may be transient [5].

Regarding stroke management and cardiovascular interventions, a study in the Journal of the American Heart Association provided a post-hoc analysis of a multicenter Phase 3 randomized controlled trial involving 1577 ischemic stroke patients who presented within 4.5 hours of onset [2].

The researchers reported that tenecteplase showed no significant difference in the distribution of serious adverse events when compared to alteplase [2].

Another study published in Circulation evaluated a Phase 3 randomized controlled trial involving 500 adults with stroke and elevated blood pressure [4].

The findings suggested that the PINGS intervention, which utilized mobile health tools and nurse case management, improved systolic blood pressure control to 67% compared to 43% in those receiving usual care [4].

Finally, a report in the Journal of the American College of Cardiology discussed transcatheter aortic valve replacement for patients with severe symptomatic aortic stenosis at low surgical risk [1].

The study found mortality rates to be comparable to surgical replacement, though it noted that transcatheter procedures may involve higher risks of regurgitation requiring reintervention [1].

Articles in This Digest

Transcatheter aortic valve replacement shows comparable mortality to surgery in severe symptomatic aortic stenosis Trial compares TAVR and surgery for aortic stenosis
This trial compared transcatheter aortic valve replacement with surgical aortic valve replacement in patients with severe symptomatic aortic stenosis at low sur…
A large trial shows that while TAVR and surgery have similar survival rates, TAVR may lead to more frequent follow-up procedures over time.
Tenecteplase shows no significant difference in serious adverse event distribution compared to alteplase Trial shows tenecteplase is as safe as alteplase for stroke
This multicenter Phase 3 randomized controlled trial post-hoc analysis involved 1577 ischemic stroke patients presenting within 4.5 hours of onset. The study fo…
A large study of over 1,500 patients confirms that the clot-busting drug tenecteplase has a similar safety profile to the standard treatment, alteplase.
Safinamide 100 mg outperforms rasagiline 1 mg and zonisamide 25 mg for motor fluctuations Safinamide beats rasagiline for Parkinson's motor symptoms
This network meta-analysis of randomized controlled trials evaluated various adjunct therapies for Asian Parkinson's disease patients with motor fluctuations. T…
For Asian Parkinson's patients, adding safinamide to levodopa reduces OFF-time more than rasagiline or zonisamide.
PINGS intervention improves systolic blood pressure control to 67% compared to 43% in usual care Nurse Case Management Improves Blood Pressure for Stroke Survivors
This Phase 3 randomized controlled trial involved 500 adults with stroke and elevated blood pressure. The PINGS intervention, involving nurse case management an…
A new mobile health program using nurse support and phone reminders helped more stroke survivors reach lower blood pressure targets.
Fecal microbiota transplantation improves motor function and constipation in patients with Parkinson disease Fecal transplants improve Parkinson's motor symptoms in short term
This meta-analysis of 220 adults with mild to moderate Parkinson disease found that fecal microbiota transplantation (FMT) significantly improved motor function…
A meta-analysis finds fecal transplants may temporarily improve motor and constipation symptoms in Parkinson's, but effects fade.
← 2026-W27 All Neurology digests → 2026-W25 →